Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings.

The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and/or contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

*Name of Committee:*                         National Cancer Institute Special Emphasis Panel; Development of Anticancer Agents.                    

*Date:*                         March 7, 2008.                    

*Time:*                         8:30 a.m. to 5 p.m.                    

*Agenda:*                         To review and evaluate contract proposals.                    

*Place:*                         The Legacy Rockville, 1775 Rockville Pike, Rockville, MD 20852.                    

*Contact Person:*                         Joyce C. Pegues, PhD, Scientific Review Officer,  Special Review and Logistics Branch, Division of Extramural Activities, NIH National Cancer Institute, 6116 Executive Boulevard, Room 7149, Bethesda, MD 20892-8329, 301-594-1286,                         *peguesj@mail.nih.gov.*

*Name of Committee:*                         National Cancer Institute  Special Emphasis Panel; Pharmacodynamic Assays.                    

*Date:*                         March 11, 2008.                    

*Time:*                         8 a.m. to 5 p.m.                    

*Agenda:*                         To review and evaluate contract proposals.                    

*Place:*                         The Legacy Hotel and Meeting Center, Bethesda, MD 20852.                    

*Contact Person:*                         Thomas M. Vollberg, PhD, Scientific Review Officer, Special Review and Logistics Branch, Division of Extramural Activities, National Cancer Institute, 6116 Executive Boulevard, Room 7142, Bethesda, MD 20892, 301-594-9582,                         *vollbert@mail.nih.gov.*

*Name of Committee:*                         National Cancer Institute  Special Emphasis Panel; Small Grants for Behavioral Research in Cancer Control.                    

*Date:*                         March 12, 2008.                    

*Time:*                         8 a.m. to 7 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         Ramada Inn Rockville, 1775 Rockville Pike, Rockville, MD 20852.                    

*Contact Person:*                         Rhonda J. Moore, PhD, Scientific Review Officer, Special Review and Logistics Branch, Division of Extramural Activities, National Cancer Institute, NIH, 6116 Executive Boulevard, Room 7151, Bethesda, MD 20892-8329, 301-451-9385,                         *moorerh@mail.nih.gov.*

*Name of Committee:*                         National Cancer Institute  Special Emphasis Panel; Biopsy Instruments and Devices that Preserve Molecular Profiles in Tumors.                    

*Date:*                         March 14, 2008.                    

*Time:*                         10:30 a.m. to 5 p.m.                    

*Agenda:*                         To review and evaluate contract proposals.                    

*Place:*                         National Institutes of Health, 6130 Executive Blvd., Conference Room J, Rockville, MD 20851, (Telephone Conference Call).                    

*Contact Person:*                         Kenneth L. Bielat, PhD, Scientific Review Officer, Special Review Logistics Branch, Division of Extramural Activities, National Cancer Institute, 6116 Executive Boulevard, Room 7147, Bethesda, MD 20892-8329, 301-496-7576,                         *bielatk@mail.nih.gov.*

*Name of Committee:*                         National Cancer Institute Special Emphasis Panel; Advanced Genomic Data Analysis and Visualization Methods for TCGA Data.                     

*Date:*                         April 2, 2008.                    

*Time:*                         8 a.m. to 5 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                               ( print page 8887)    

*Place:*                         Courtyard Gaithersburg Washingtonian Center, 204 Boardwalk Place, Gaithersburg, MD.                     

*Contact Person:*                         Thomas M. Vollberg, PhD, Scientific Review Officer, Special Review and Logistics Branch, Division of Extramural Activities, National Cancer Institute, 6116 Executive Boulevard, Room 7142, Bethesda, MD 20892, 301-594-9582,                         *vollbert@mail.nih.gov.*

*Name of Committee:*                         National Cancer Institute Special Emphasis Panel; Biosensors for Early Cancer Detection & Risk Assessment/Novel & Improved Methods to Measure Cancer Epigenetic Biomarkers.                     

*Date:*                         April 7, 2008.                    

*Time:*                         8 a.m. to 5 p.m.                     

*Agenda:*                         To review and evaluate contract proposals.                     

*Place:*                         Gaithersburg Hilton, 620 Perry Parkway, Gaithersburg, MD 20877.                     

*Contact Person:*                         Lalita D. Palekar, PhD, Scientific Review Officer, Special Review and Logistics Branch, Division of Extramural Activities, National Cancer Institute, 6116 Executive Boulevard, Room 7141, Bethesda, MD 20892-7405, 301-496-7575,                         *palekarl@mail.nih.gov.*

*Name of Committee:*                         National Cancer Institute Special Emphasis Panel; System to Analyze and Support Biomarker Research and Development Strategies.                     

*Date:*                         April 8, 2008.                    

*Time:*                         8 a.m. to 5 p.m.                     

*Agenda:*                         To review and evaluate contract proposals.                     

*Place:*                         Gaithersburg Hilton, 620 Perry Parkway, Gaithersburg, MD 20877.                    

*Contact Person:*                         Lalita D. Palekar, PhD, Scientific Review Officer, Special Review and Logistics Branch, Division of Extramural Activities, National Cancer Institute, 6116 Executive Boulevard, Room 7141, Bethesda, MD 20892-7405, 301-496-7575,                         *palekarl@mail.nih.gov.*

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer Control, National Institutes of Health, HHS)

Dated: February 8, 2008.

Jennifer Spaeth,

Director, Office of Federal Advisory Committee Policy.

[FR Doc. 08-692 Filed 2-14-08; 8:45 am]

BILLING CODE 4140-01-M